Margins
← Отчётные звонки
01
02
03
04 05 06
Тон
Капзатраты
A1 A2 A3 A4
IFF
FY2026 Q1
В пределах ожиданий
Отчётный звонок International Flavors & Fragrances, Inc.
Вывод Buzzberg
Q1 EBITDA margin highest since Q2 2022
IFF reported a strong Q1 2026 with better-than-expected volume growth and margin expansion, but management maintained full-year guidance, citing significant inflation and Middle East conflict-related headwinds expected to impact Q2 and the rest of the year. Strong Q1: Revenue of >$2.7B (+3% CC) and Adjusted EBITDA of $568M (+8% CC) beat internal expectations, driven by volume across all segments.
Вывод Buzzberg Q1 EBITDA margin highest since Q2 2022 IFF reported a strong Q1 2026 with better-than-expected volume growth and margin expansion, but management maintained full-year guidance, citing significant inflation and Middle East conflict-related headwinds expected to impact Q2 and the rest of the year. Strong Q1: Revenue of >$2.7B (+3% CC) and Adjusted EBITDA of $568M (+8% CC) beat internal expectations, driven by volume across all segments. Читать полный анализСвернуть анализ
IFF reported a strong Q1 2026 with better-than-expected volume growth and margin expansion, but management maintained full-year guidance, citing significant inflation and Middle East conflict-related headwinds expected to impact Q2 and the rest of the year. Strong Q1: Revenue of >$2.7B (+3% CC) and Adjusted EBITDA of $568M (+8% CC) beat internal expectations, driven by volume across all segments.
- Full-year guidance maintained at $10.5B-$10.8B revenue and $2.05B-$2.15B EBITDA, despite a stronger Q1, due to a more cautious outlook for Q2.
- Q2 EBITDA expected to be lower than Q1 due to Middle East conflict impacting fine fragrance demand, inflation starting to hit, and pricing surcharges not yet fully implemented.
- Divestiture of commodity soy business to Bungie closed in March; sale process for food ingredients is advanced with an update expected by Q2 call.
Выручка$2.741B+6% к/к
EPS$1.25+56% к/к
Валовая маржа37.14%Факт
Операционная маржа10.18%Факт
6 подтверждённых тезисов
Что важно сейчас
Самые значимые изменения по итогам звонка.
Portfolio
Food ingredients divestiture progressing with multiple buyers
Guidance
Q2 EBITDA expected lower due to Middle East conflict
Показать ещё 3 тезиса
Pricing
Pricing surcharges to offset inflation, but lag in Q2
Product Strategy
De-emphasizing commodity fragrance ingredients sales
Cash Flow
Working capital and cash flow improvement key focus
Отчётный период
Фактические результаты
| Показатель | Факт | Изменение |
|---|---|---|
| Выручка | $2.741B | +6% к/к |
| EPS | $1.25 | +56% к/к |
| Валовая маржа | 37.14% | Факт |
| Операционная маржа | 10.18% | Факт |
| Свободный денежный поток | $0.092B | -29% к/к |
| Капзатраты | $0.165B | Факт |
Прогнозные данные
Прогноз компании
| Показатель | Период | Диапазон | Середина | Статус |
|---|---|---|---|---|
| Операционная маржа | FY2026 | $2.05B–$2.15B | $2.1B | Подтверждён |
| Выручка | FY2026 | $10.5B–$10.8B | $10.65B | Подтверждён |
AI, капзатраты и спрос
Оценка менеджмента
Cautiously Optimisti
Management reaffirmed full-year guidance despite acknowledging ongoing macro uncertainty and Middle East conflict, expressing confidence in execution while highlighting challenges ahead.
Инвестиции и мощности
Management mentioned opening a fermentation-based enzyme production site in Argentina and a household care application laboratory in Brazil to support health and biosciences growth in Latin America. CapEx was $165 million year-to-date, roughly 6% of sales.
все упомянутые компании ниже: 1
Компаниис момента звонка
Цепочка поставок
ANDURIL
Цепочка поставок
Eric Fehrwald
This is a low-confidence, periphery mention of Anduril based on a likely mis-transcription of 'Arellito' site; no substantive signal about the private company is provided.
Доказательства
“In Q1, we also announced regional production and added innovation capabilities to better support the continued strong growth of our health and biosciences business in Latin America.”
Внешние сигналы
Альфа цепочки поставок · 4с момента звонка
Q2 2026 EBITDA is guided to be lower than the $568 million reported in Q1, driven by a temporary slowdown in Middle East fine fragrance volume and customer supply chain challenges (e.g., packaging)
Доказательства
“We anticipate that fine fragrance volume in the Middle East will be impacted in the second quarter due to slower market demands, but also temporary supply chain challenges our customers are facing, such as getting packaging into the region.”
IFF is facing double-digit increases in energy and logistics costs immediately, before raw material inflation hits, prompting it to implement pricing surcharges with customers.
Доказательства
“We're seeing energy and logistic charges rising, and we haven't really fully implemented our surcharges in place yet, and that will happen over the course of the quarter.”
IFF is explicitly de-emphasizing its 'commodity' fragrance ingredients business (roughly half of its ~$500M annual ingredient sales) due to intense price competition from Indian and Chinese producers.
Доказательства
“On the commodity side, that's the part that's very, very challenged and challenged by Indian producers, Chinese producers, and it's an area that we need to continue to have competitive costs for our internal formulation use but we're de-em…”
IFF's food ingredients business sale process is advanced with multiple buyers in second-round due diligence; an update is expected by the Q2 earnings call.
Доказательства
“We are running a very disciplined process and it's going very well with several potential buyers going through second round of due diligence and the feedback has been very positive so far.”
Методология и полнота
Анализ основан только на заявлениях менеджмента. Показаны все подтверждённые упоминания компаний: 1. Фактические результаты и прогнозы разделены. Публичные доказательства ограничены восемью короткими атрибутированными цитатами. AI-анализ может быть неполным или ошибочным — проверяйте важные утверждения по первоисточнику.